Gael Forterre - 17 Mar 2026 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Reporting relationship: Chief Commercial Officer
Issuer ticker: VNRX
Reported as of: 17 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Mar 2026, 16:30:29 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Gael Forterre

Key filing fact

Gael Forterre filed Form 4 for VOLITIONRX LTD (VNRX) on 19 Mar 2026.

Key facts

This page summarizes Gael Forterre's Form 4 filing for VOLITIONRX LTD (VNRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Mar 2026, 16:30.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001841637 Primary reporting owner

Forterre Gael

Relationship: Chief Commercial Officer
Address: 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON
Signature: /s/ Gael Forterre
Signature date: 19 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNRX transaction

Common Stock

Tax liability

Transaction value
Shares: -5,251
Change %: -1.6%
Price: $0.1900^*
Shares after: 331,338
Date: 17 Mar 2026
Ownership: Direct
Footnotes: F1

VNRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,000
Date: 17 Mar 2026
Ownership: By Spouse

VNRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,500
Date: 17 Mar 2026
Ownership: By Armorica Partners, LLC
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,700 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Footnote F2

These shares of common stock are managed by Armorica Partners, LLC (formerly Armori Capital Management, LLC) ("Armorica Partners"). Mr. Forterre is the managing director and sole shareholder of Armorica Partners and has voting and dispositive control over the shares held by Armorica Partners. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.